Cano Health (CANO) Misses Q3 EPS by 20c, Revenue Misses

Cano Health (NYSE: CANO) reported Q3 EPS of ($0.23), $0.20 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $665 million versus the consensus estimate of $719.18 million.

For earnings history and earnings-related data on Cano Health (CANO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49